Contact Gilead Sciences Customer Service

Immunomedics, Kite Pharma

Gilead Sciences, Inc. is a US-based biopharmaceutical company. It was founded in June 1987. Gilead Sciences focuses on the research and development of medicines in areas of unmet medical need including oncology, cardiovascular, HIV/AIDS, inflammation, and liver diseases. The company owns such brands as Atripla, Complera, Descovy, Emtriva, Tybost, etc. Gilead is a member of the NASDAQ Biotechnology Index. Currently, Gilead Sciences is working on 42 clinical-stage programs. The Phase 1 clinical trials of the Veklury Covid-19 vaccine candidate is one of them. In May 2020, the Ministry of Health, Labour, and Welfare of Japan granted regulatory approval of the Veklury vaccine (Remdesivir) as a treatment for SARS-CoV-2 infection. In the United States, the Veklury vaccine is the only FDA-approved treatment for COVID-19. The Veklury vaccine candidate prevents replication of SARS-CoV-2. It is used to treat people infected with Covid-19 who require hospitalization. The benefits of Veklury were demonstrated in three randomized, controlled clinical trials. In addition to Gilead Sciences, such companies as Moderna, Pfizer, and Johnson and Johnson continue verifying the efficacy and safety of their Covid-19 vaccine candidates to respond to challenges posed by coronavirus pandemic.